MiniMed (MMED) Depreciation & Amortization (CF) (2025 - 2026)
MiniMed (MMED) posted Depreciation & Amortization (CF) of $41.0 million for Q3 2026, up 5.13% quarter-over-quarter from $39.0 million in Q2 2026, and up 5.13% YoY from $39.0 million in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $41.0 million in Q3 2026.
- For the quarter ending Q3 2026, Depreciation & Amortization (CF) rose 5.13% year-over-year to $41.0 million; the trailing twelve-month figure through Jul 2026 stood at $157.0 million (changed N/A YoY), and the FY2026 full-year result was $156.0 million, up 9.09% from the prior year.
- Depreciation & Amortization (CF) was $41.0 million for Q3 2026 at MiniMed, up from $39.0 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $41.0 million in Q3 2026 to a low of $38.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 123.80 Mn |
| 10 | MiniMed | 6.37 Bn | 6.17 Bn | 465.00 Mn | 41.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 41.00 Mn |
| Apr 24, 2026 | 39.00 Mn |
| Apr 25, 2025 | 38.00 Mn |